569 Preliminary Study: Increased Levels of cGMP in Recipients of Continuous Flow LVADs, Implications for Gastrointestinal Bleeding von Grosman-Rimon, L, Cherney, D.Z.I, Bar-Ziv, S. Pollock, McDonald, M.A, Tumiati, L, Rao, V

Volltext

774 Inflammatory Markers and Cardiopulmonary Exercise Testing in Continuous Flow LVAD Recipients von Grosman-Rimon, L, Cherney, D.Z.I, Pollock Bar-Ziv, S, Tumiati, L, McDonald, M.A, Jacobs, I, Rao, V

Volltext

Elevated Levels of Inflammation in Patients on Long-Term Continuous Flow Left Ventricular Assist Device (CF-LVAD) Support von Grosman-Rimon, L, Cherney, D.Z.I, McDonald, M.A, Pollock Bar-Ziv, S, Tumiati, L, Mociornita, A, Ghashghai, A, Chruscinski, A, Rao, V

Volltext

IDF2022-0796 Sustained weight loss with ertugliflozin in patients with T2D and atherosclerotic cardiovascular disease in VERTIS CV von Cosentino, F., Dagogo-Jack, S., Frederich, R., Cannon, C.P., Cherney, D.Z.I., Mancuso, J.P., Wynant, W., Liu, J., Cater, N.B., Pratley, R.E.

Volltext

Acute hyponatraemia and ‘ecstasy’: insights from a quantitative and integrative analysis von Cherney, D.Z.I., Davids, M.R., Halperin, M.L.

Volltext

The Influence of Gender, Cyclooxygenase-2 Inhibition, and Hyperglycemia on Vascular Function in Uncomplicated Type 1 Diabetes Mellitus von Cherney, D.Z.I, Miller, J.A, Scholey, J.W, Dekker, M.G, Sochett, E.B, Slorach, C, Bradley, T.J

Volltext

P.034 THE INFLUENCE OF GENDER, CYCLOOXYGENASE-2 INHIBITION, AND HYPERGLYCEMIA ON VASCULAR FUNCTION IN UNCOMPLICATED TYPE 1 DIABETES MELLITUS von Cherney, D.Z.I., Miller, J.A., Scholey, J.W., Dekker, M.G., Sochett, E.B., Slorach, C., Bradley, T.J.

Volltext

Supplementary Material for: Initial eGFR Changes with Ertugliflozin and Associations with Clinical Parameters: Analyses from the VERTIS CV Trial von D.Z.I., Cherney, F., Cosentino, S., Dagogo-Jack, D.K., McGuire, R.E., Pratley, R., Frederich, M., Maldonado, C.-C., Liu, A., Pong, C.P., Cannon, Investigators, on behalf of the VERTIS CV

Volltext bestellen

Supplementary Material for: Impact of Cardio-Renal-Metabolic Comorbidities on Cardiovascular Outcomes and Mortality in Type 2 Diabetes Mellitus von Cherney D.Z.I., Repetto, E., Wheeler, D.C., Arnold, S.V., MacLachlan, S., Hunt, P.R., Chen, H., Vora, J., Kosiborod, M.

Volltext bestellen